Value_of_MR_imaging_in_differentiating_benign_from_malignant_soft-tissue_masses:_study_of_95_lesions._MR_imaging_has_largely_replaced_CT_as_the_technique_of_choice_for_preoperative_staging_of_patients_with_soft-tissue_masses._Whether_MR_imaging_can_be_used_to_differentiate_benign_from_malignant_masses_is_controversial._Our_experience_suggests_that_MR_imaging_often_can_characterize_soft-tissue_masses_accurately._To_evaluate_this_question_further,_we_studied_95_consecutive_lesions_(50_benign_and_45_malignant)._Consecutive_cases_were_selected_to_simulate_our_clinical_practice._Surgical_proof_was_available_for_all_masses_except_hematomas,_for_which_clinical_follow-up_confirmed_the_diagnosis._MR_images_were_interpreted_twice_by_three_radiologists._The_first_review_was_accomplished_without_any_clinical_history_and_the_second_review_with_clinical_history._Reviewers_were_asked_to_classify_the_lesion_as_benign_or_malignant_on_the_basis_of_their_clinical_knowledge_and_analysis_of_MR_image_features_(size,_lesion_margin,_signal_homogeneity,_and_neurovascular_or_bone_involvement)._Although_interpretation_varied_somewhat_because_of_the_experience_of_the_reviewers,_the_specificity_and_accuracy_of_diagnosis_averaged_90%_for_both_benign_and_malignant_lesions._Negative_predictive_value_for_malignancy_averaged_94%_among_the_three_reviewers._MR_imaging_is_the_technique_of_choice_for_identification_and_characterization_of_soft-tissue_masses._The_nature_of_the_lesion_(benign_vs_malignant)_can_be_determined_in_the_majority_of_cases.